| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,836 |
6,003 |
$609K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,301 |
2,082 |
$202K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
708 |
492 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
703 |
671 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
148 |
134 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,486 |
1,373 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
370 |
361 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
36 |
34 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
86 |
70 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,381 |
619 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,031 |
941 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
111 |
87 |
$1K |
| 81003 |
|
29 |
26 |
$24.00 |
| 3074F |
|
1,737 |
1,610 |
$0.00 |
| 3079F |
|
312 |
281 |
$0.00 |
| 87807 |
|
14 |
14 |
$0.00 |
| 3075F |
|
56 |
50 |
$0.00 |
| 3078F |
|
1,245 |
1,147 |
$0.00 |
| 3077F |
|
12 |
12 |
$0.00 |